Ubiquilin-2-positive neuronal inclusions are seen in affected motor neurons of some ALS and ALS/FTD patients, and ALS-linked mutations in ubiquilin 2 have also been shown to impair protein degradation mediated by the UPS4, 20. The gene discussed is UBQLN2; the disease is frontotemporal dementia.